In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents
about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroIn vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinIn vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeIn vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinoloneIn vitro activity of PD 127,391, an enhanced-spectrum quinoloneAnti-Mycobacterium avium activity of quinolones: in vitro activitiesChemotherapeuticsComparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.Studies on the antimicrobial properties of N-acylated ciprofloxacins.Pharmacokinetics of ciprofloxacin in cystic fibrosis.Recent progress in novel macrolides, quinolones, and 2-pyridones to overcome bacterial resistance.Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.Ecological implications of an improved direct viable count method for aquatic bacteriaStereoselective synthesis of β-hydroxy enamines, aminocyclopropanes, and 1,3-amino alcohols via asymmetric catalysis.Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.In vivo evaluation of NM441, a new thiazeto-quinoline derivative.In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens.In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections.Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent.Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice.Ciprofloxacin activity in cyst fluid from polycystic kidneys.Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacinIn vitro and in vivo activities of QA-241, a new tricyclic quinolone derivativeStructure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocciIn vitro susceptibility of Capnocytophaga species to antimicrobial agents.Effect of peritoneal dialysis fluid and pH on bactericidal activity of ciprofloxacin.Ciprofloxacin pharmacokinetics in patients with normal and impaired renal functionInteractions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic ratsIn vitro activity of DR-3355, an optically active ofloxacinPenetration of pefloxacin into cerebrospinal fluid of patients with meningitisIn vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).Activities of new quinoline derivatives against genital pathogens.
P2860
Q24670241-52076FA9-15E8-49D7-9315-79B79679728CQ24671010-E375C437-9F45-4393-BA76-4D41E85B5EDCQ24685742-06346ACF-F98E-4865-9E65-4F7D2482F0C1Q28326997-0BC51D7D-2BC0-4ADE-914A-8955F1F928D8Q28361070-786E9D01-A88E-4A5F-AF6A-3988199DF77BQ28378348-8C523415-0919-434D-92D2-D4E026E31309Q30047670-5B174071-BC06-4960-85CE-557594CB1595Q30451302-0A9B9394-2715-4C72-AA08-80B6A235F8F4Q31096940-DED30A01-7A44-401C-BAF4-F663A6D61375Q33741046-9038EA08-DCF4-40F1-BCF3-215D82C70FB3Q33771929-314E69B3-AD1E-486C-B79D-4DD68D551D38Q33983352-7CEDBC7F-E56E-4CCE-B99C-58B1D6396802Q34424398-F6EF1FBA-D3CF-4398-AC16-3A375DF75EB7Q34458109-CC3C3810-15F8-4725-837D-32B8A3428C8BQ34537808-13173102-C4CA-4C66-8850-0CF3AE9BC4A3Q34566027-4E96B2C1-D641-4BE7-9E02-DEFBCA622F90Q34567225-A50A993A-B224-4459-870F-24E9882B50A9Q34681603-2529CE83-D734-45ED-9AB4-3B670C09992BQ34729788-A85052E3-6158-4937-85AA-0A49FD42A808Q34734520-E276BA30-3091-4813-9BDF-AA717F8E2A07Q35111654-9728ABCE-BE26-4799-A936-42EC52A983D3Q35139147-13F8692A-EF09-42CF-BAA8-5F95A85C78CEQ35252460-3973F524-6769-4484-96A5-DE287BE19724Q35284580-1DC3ACA7-7F3B-495A-8F2A-9396BB2DE6AEQ35288542-7E8935F1-635E-4443-BC72-ADE84914032CQ35308712-83583647-1A0F-48C5-80D9-FD53A006DDF1Q35319641-FDB00A72-0423-47A8-98C6-3F9DEC9B1253Q35340351-5EDFF7EC-9463-45EB-843A-6B7C3393D661Q35354313-92851982-E631-46B0-A6C3-F67B97F3FA35Q35361659-28A5C341-6C81-4862-AF40-4721151AF23AQ35537106-5DE7A861-2124-440F-8CF8-5048B01529F7Q35539396-2F10F7B1-684F-4F64-AAFC-81F6E85E216CQ35539825-AF4283FD-345A-4F20-AFD9-1BA95E18AD8CQ35541583-BEFBD8E4-0C51-439E-8E9A-7E402B393A95Q35543422-B1C1E68B-86DC-44D7-8FFB-0485607D0CF3Q35543546-09AF4938-6C00-4E4C-BE44-CBF7B62C4583Q35563775-EE927B2B-942B-47D3-AB96-2EBF1D73EA41Q35568119-23F63DEB-E0B2-42FE-B045-2CB95BCC485BQ35568734-5158A837-7060-4E17-8A8E-4C3A25D72F7CQ35568919-0B85A1F6-BA94-4962-A413-9384428B7899
P2860
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents
description
1983 nî lūn-bûn
@nan
1983 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
name
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@ast
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@en
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@nl
type
label
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@ast
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@en
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@nl
prefLabel
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@ast
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@en
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@nl
P2093
P3181
P356
P1476
In vitro activity of Bay 09867 ...... of other antimicrobial agents
@en
P2093
P304
P3181
P356
10.1128/AAC.23.4.559
P407
P577
1983-04-01T00:00:00Z